<abstract xmlns="http://www.w3.org/1999/xhtml">

<bold>Background</bold>: Insulin autoimune syndrome (IAS), also known as Hirata’s disease, is a rare cause of spontaneous hyperinsulinemic hypoglicemia characterised by the presence of autoantibodies directed against human insulin (IAA).
<bold>Case Report</bold>: A 48-year-old Caucasian female patient with IAS was studied in two different periods, for 7 days each, using a continuous monitoring system (CGM) under various treatment regimens, i.e diet modification and corticosteroids therapy.
<bold>Discutions</bold>: The use of CGM in autoimmune hypoglycemia is encouraged and must be taken into consideration in order to prevent episodes of hypoglicemia. Including of IAS and quantification of IAA in differential diagnosis in patients with hypoglicemia episodes and negative imaging results can prevent patients from going through unnecessary procedures.
</abstract>

Background: Insulin autoimune syndrome (IAS), also known as Hirata’s disease, is a rare cause of spontaneous hyperinsulinemic hypoglicemia characterised by the presence of autoantibodies directed against human insulin (IAA).
Case Report: A 48-year-old Caucasian female patient with IAS was studied in two different periods, for 7 days each, using a continuous monitoring system (CGM) under various treatment regimens, i.e diet modification and corticosteroids therapy.
Discutions: The use of CGM in autoimmune hypoglycemia is encouraged and must be taken into consideration in order to prevent episodes of hypoglicemia. Including of IAS and quantification of IAA in differential diagnosis in patients with hypoglicemia episodes and negative imaging results can prevent patients from going through unnecessary procedures.

Use of the continuous glucose monitoring system in the management of hypoglicemia in insulin autoimmune syndrome

“Iuliu Hatieganu” University of Medicine and Pharmacy

George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures

Acta Marisiensis - Seria Medica

This work is licensed under the Creative Commons Attribution 4.0 International License.

Background: Insulin autoimune syndrome (IAS), also known as Hirata’s disease, is a rare cause of spontaneous hyperinsulinemic hypoglicemia characterised by the...

Use of the continuous glucose monitoring system in the management of hypoglicemia in insulin autoimmune syndrome

Online veröffentlicht: 11. Juli 2022

Seitenbereich: 89 - 92

Eingereicht: 03. Jan. 2022

Akzeptiert: 31. Mai 2022

DOI: https://doi.org/10.2478/amma-2022-0011

Schlüsselwörter
insulin autoimune syndrome, Hirata’s disease, continuous monitoring system, insulin autoantibodies

© 2022 Andrada Raluca Pop et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Use of the continuous glucose monitoring system in the management of hypoglicemia in insulin autoimmune syndrome

Online veröffentlicht: 11. Juli 2022

Seitenbereich: 89 - 92

Eingereicht: 03. Jan. 2022

Akzeptiert: 31. Mai 2022

DOI: https://doi.org/10.2478/amma-2022-0011

Schlüsselwörterinsulin autoimune syndrome, Hirata’s disease, continuous monitoring system, insulin autoantibodies

© 2022 Andrada Raluca Pop et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Schlüsselwörter
insulin autoimune syndrome, Hirata’s disease, continuous monitoring system, insulin autoantibodies